Andres Hernandez-Aguilar
Instituto Oncologico Dr Rosell
Barcelona, CT, Spain
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.
Journal: Journal for immunotherapy of cancer
Published: July 08, 2026
Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 15, 2026
Expression of LIFR in tumor and SHOC2, YAP1 in plasma mRNA as potential biomarkers in KRAS G12C NSCLC.
Journal: Scientific reports
Published: February 19, 2026
Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer.
Journal: Cancers
Published: April 19, 2023
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Journal: Molecular cancer
Published: February 27, 2023
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques.
Journal: Molecular oncology
Published: January 04, 2023
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC.
Journal: JTO clinical and research reports
Published: October 26, 2022
Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer.
Journal: Pharmaceutics
Published: August 08, 2022
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens.
Journal: Molecular oncology
Published: August 16, 2021
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer.
Journal: Molecular oncology
Published: September 09, 2020
Unmasking the expression of PD-L1 in Myeloid Derived Suppressor Cells: A case study in lung cancer to discover new drugs with specific on-target efficacy.
Journal: Translational oncology
Published: July 29, 2020
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform.
Journal: Translational cancer research
Published: October 03, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026